Please assess the completion status of the following clinical trial:

Trial Title: StrataGraft® Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Men and women aged 18-65 years, inclusive~2. Written informed consent~3. Sufficient healthy skin identified and reserved as a donor site in the event that the StrataGraft treatment site requires autografting~4. Complex skin defects of up to 49% Total Body Surface Area (TBSA) requiring excision and autografting~   * Total skin defect may consist of more than one wound area~5. Full-thickness complex skin defects requiring excision and autografting~6. Study treatment sites on the torso and limbs may be up to 200 cm2 in cohort 1 and 400 cm2 in cohort 2~7. For thermal burns only, first excision and grafting of treatment sites~Exclusion Criteria:~1. Pregnant women and prisoners~2. Subjects receiving systemic immunosuppressive therapy~3. Subjects with a known history of malignancy~4. Preadmission insulin-dependent diabetic subjects~5. Subjects with concurrent conditions that in the opinion of the investigator may compromise subject safety or study objectives~6. Expected survival of less than three months~7. Participation in the treatment group of an interventional study within the 90 days prior to enrollment~8. Chronic wounds~9. The face, head, neck, hands, feet, buttocks, perineum, and area over joints~10. Treatment sites with exposed tendon or bony prominences~11. Chemical and electrical burns~12. Treatment sites adjacent to unexcised eschar~13. Clinical suspicion of infection at the anticipated treatment sites

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- StrataGraft skin tissue (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).